Security
Aeolus Pharmaceuticals, Inc. Common Stock · AOLS
AOLSOTCCommon stockCurrentCIK 1261734Updated Nov 16, 2026
Name history
INCARA PHARMACEUTICALS CORP · through Jul 20, 2004INCARA INC · through Dec 4, 2003
AOLS price & chart
Loading TradingView…
OTC:AOLS on TradingView ↗In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2016 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 4,167,000Source | 1,777,000Source | 3,580,000Source | 1,966,000Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 3,155,000Source | 94,000Source | 1,517,000Source | 869,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 750,000Source | 1,585,000Source | 1,559,000Source | 370,000Source |
| Assets, CurrentUSD | 4,135,000Source | 1,745,000Source | 3,548,000Source | 1,935,000Source |
| Prepaid Expense and Other Assets, CurrentUSD | 230,000Source | 45,000Source | 46,000Source | 39,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 972,000Source | 2,622,000Source | 1,995,000Source | 1,261,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 5,000Source | 5,000Source | 5,000Source |
| Common Stock, Value, IssuedUSD | 1,520,000Source | 1,359,000Source | 1,359,000Source | 1,346,000Source |
| Retained Earnings (Accumulated Deficit)USD | -190,188,000Source | -186,630,000Source | -184,002,000Source | -183,922,000Source |
| Stockholders' Equity Attributable to ParentUSD | 3,195,000Source | -845,000Source | 1,585,000Source | 705,000Source |
| Additional Paid in Capital, Common StockUSD | 191,863,000Source | 184,421,000Source | 184,223,000Source | 183,276,000Source |
| Liabilities and EquityUSD | 4,167,000Source | 1,777,000Source | 3,580,000Source | 1,966,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 972,000Source | 2,622,000Source | 1,995,000Source | 1,261,000Source |
| Additional Financial Items | ||||
| Deferred Tax Liabilities, NetUSD | 94,000Source | -113,000Source | — | — |
cash flow · annual statements
| Line item | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Share-based Payment Arrangement, Noncash ExpenseUSD | 141,000Source | 178,000Source | 635,000Source | 861,000Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | -835,000Source | 26,000Source | 1,189,000Source | -411,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -3,109,000Source | -2,443,000Source | 323,000Source | -2,970,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | 0Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 6,170,000Source | 1,020,000Source | 325,000Source | 3,558,000Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 141,000Source | 178,000Source | 635,000Source | 861,000Source |
| Amortization of Deferred ChargesUSD | 21,000Source | 405,000Source | 230,000Source | -555,000Source |
| Amortization of Debt Issuance CostsUSD | — | — | — | 0Source |
| DepreciationUSD | — | — | 0Source | 6,000Source |
| Derivative, Gain (Loss) on Derivative, NetUSD | — | — | 0Source | -510,000Source |
| General and Administrative ExpenseUSD | 2,468,000Source | 2,228,000Source | 2,745,000Source | 3,266,000Source |
| Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | 2,000Source |
| Net Income (Loss) Attributable to ParentUSD | -3,558,000Source | -2,628,000Source | -80,000Source | -3,208,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -6,044,000Source | -2,628,000Source | -80,000Source | -3,208,000Source |
| Proceeds from Issuance of Common StockUSD | 2,005,000Source | — | 0Source | 3,616,000Source |
income statement · annual statements
| Line item | FY 2016 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|
| Total RevenueUSD | — | 3,111,000Source | 9,631,000Source | 3,928,000Source |
| Operating Income (Loss)USD | -3,273,000Source | -2,626,000Source | -80,000Source | -2,698,000Source |
| Income Tax Expense (Benefit)USD | 2,000Source | 2,000Source | 2,000Source | 2,000Source |
| Net Income (Loss) Attributable to ParentUSD | -3,558,000Source | -2,628,000Source | -80,000Source | -3,208,000Source |
| Earnings Per Share, BasicUSD per share | -0.04Source | -0.02Source | 0Source | -0.03Source |
| Earnings Per Share, DilutedUSD per share | -0.04Source | -0.02Source | 0Source | -0.03Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 148,668Source | 135,883Source | 134,667Source | 106,554Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 148,668Source | 135,883Source | 134,667Source | 106,554Source |
| Additional Financial Items | ||||
| Costs and ExpensesUSD | 5,349,000Source | 5,737,000Source | 9,711,000Source | 6,626,000Source |
| General and Administrative ExpenseUSD | 2,468,000Source | 2,228,000Source | 2,745,000Source | 3,266,000Source |
| Interest ExpenseUSD | 285,000Source | 2,000Source | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -6,044,000Source | -2,628,000Source | -80,000Source | -3,208,000Source |
| Other General and Administrative ExpenseUSD | 141,000Source | 178,000Source | 624,000Source | 841,000Source |
| Preferred Stock Dividends and Other AdjustmentsUSD | — | 0Source | 0Source | 0Source |
| Research and Development ExpenseUSD | 2,881,000Source | 3,509,000Source | 6,966,000Source | 3,360,000Source |